Neuroimmunologic disorders in pregnancy

Handb Clin Neurol. 2020:172:105-123. doi: 10.1016/B978-0-444-64240-0.00006-4.

Abstract

Pregnancy influences the course of neuroimmunologic conditions, which include multiple sclerosis (MS), neuromyelitis optica spectrum disorder, and autoimmune encephalitis. The outcomes differ significantly for each disorder, reflecting the impact of hormonal changes, T-cell subsets, and placental factors on disease pathogenesis. In recent years, numerous data have emerged regarding MS activity throughout pregnancy and postpartum. Historically, the misconception that pregnancy worsens MS outcomes led patients to abstain from childbearing. Now, more women with these disorders, empowered by up-to-date information and better baseline disease control, are choosing to conceive. Nevertheless, the management of MS and related disorders in the pregnancy and postpartum period is complicated and requires a nuanced approach. Since standardized treatment guidelines around pregnancy are currently lacking, neurologists, together with obstetricians, must engage patients in a shared decision-making process that weighs the benefits to the mother and risks to the fetus. This chapter outlines the pathophysiology of neuroimmunologic disorders during pregnancy and postpartum, the impact of these diseases on childbearing, including fertility, pregnancy, delivery, and peurperium, as well as existing recommendations for treatment.

Keywords: Autoimmune encephalitis; Demyelination; Disease modifying drugs; Immune tolerance; Lymphocytes; Multiple sclerosis; Neuroimmunology; Neuromyelitis optica spectrum disorder.

Publication types

  • Review

MeSH terms

  • Encephalitis*
  • Female
  • Humans
  • Multiple Sclerosis* / epidemiology
  • Multiple Sclerosis* / therapy
  • Neuromyelitis Optica*
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications* / epidemiology